PROFLOZIN MET (Empagliflozin 12.5mg + Metformin hydrochloride 500mg) x 30 TABLETS.

Rated 0 out of 5
(0 customer reviews)

Description: Proflozin Met Tablet is a combination medication that improves blood sugar control in adults with type 2 diabetes. It combines empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide, to help manage blood glucose levels effectively.

11,600.00

Hurry Up! Sales Ends In:

In stock

Category:

Guaranteed Safe Checkout

PROFLOZIN MET (Empagliflozin 12.5mg + Metformin hydrochloride 500mg) x 30 TABLETS.
Generic name: Empagliflozin and Metformin.
Brand name: Proflozin
Class: Antidiabetic Combination.
Pack size: 30 Tablets.
Form: Tablets.
Strength: 12.5/500 mg.
Amount: ₦‎11,600.

Description: Proflozin Met Tablet is a combination medication that improves blood sugar control in adults with type 2 diabetes. It combines empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide, to help manage blood glucose levels effectively.

Key features:
• It is a dual action drug that combines the benefits of empagliflozin and metformin.
• It helps lower blood sugar levels in type 2 diabetes patients.
• It reduces the risk of cardiovascular events in patients with type 2 diabetes and heart disease.
• Available in a single tablet for ease of use.

Side Effects:
• Common side effects include stomach pain, diarrhoea, constipation, headache, cold symptoms (runny or stuffy nose, sneezing, sore throat).

Caution:
• Keep out of reach of children.
• Store in a cool, dry place away from direct sunlight.
• Not for use in patients with type 1 diabetes.
• Ensure adequate hydration to prevent dehydration.
• Consult a healthcare provider before use if you have kidney or liver issues.
• Avoid use during pregnancy and breastfeeding unless advised by a doctor.

Reviews

There are no reviews yet.

Be the first to review “PROFLOZIN MET (Empagliflozin 12.5mg + Metformin hydrochloride 500mg) x 30 TABLETS.”

Your email address will not be published. Required fields are marked *

Back To Top